Hydrochloric Acid → (R)-3-pyrrolidin-3-yl-4H-[1,2,4]thiadiazol-5-one

HRID 1040419Notes

Reaction equation

HRID 1040419 reaction equation
C(OC([N:8]1[CH2:12][CH2:11][C@@H:10]([C:13]2[NH:17][C:16](=[O:18])[S:15][N:14]=2)[CH2:9]1)=O)(C)(C)C.Cl.O1CCOCC1>CO>[NH:8]1[CH2:12][CH2:11][C@@H:10]([C:13]2[NH:17][C:16](=[O:18])[S:15][N:14]=2)[CH2:9]1

Participants

5

Reactant 3

HCID 313Hydrochloric AcidHCID 312751,4-DioxaneHCID 136383467(R)-3-(5-oxo-4,5-dihydro-[1,2,4]thiadiazol-3-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester

Product 1

HCID 136383465(R)-3-pyrrolidin-3-yl-4H-[1,2,4]thiadiazol-5-oneYield 83%

Reagents, catalysts & solvents 1

HCID 887MethanolSolvent

Procedure

(R)-3-(5-Oxo-4,5-dihydro-[1,2,4]thiadiazol-3-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester (420 mg, 1.55 mmol) was dissolved in methanol (15 mL). 4M HCl in dioxane (0.70 mL, 2.80 mmol) was then added. The solution was stirred overnight. The reaction was concentrated in vacuo. The residue was purified by reverse phase HPLC to afford (R)-3-pyrrolidin-3-yl-4H-[1,2,4]thiadiazol-5-one (220 mg, 1.28 mmol, 83%) as a white solid.

Workup

  1. concentrationThe reaction was concentrated in vacuo
  2. customThe residue was purified by reverse phase HPLC

Sources & evidence

ORD record
ord-926a9de67ad74b1491ce8ad56a12db9e
Source dataset
uspto-grants-2013_10
Patent number
US08552205B2

Reaction notes

Loading…